Fusion Pharmaceuticals Inc, a spin out of the Centre for Probe Development and Commercialization (CPDC), has secured US$25 million in series ‘A’ financing to support and accelerate development of new next-generation therapeutics that precisely target cancer cells. The funding round is led by Johnson & Johnson Innovation – JJDC Inc, and includes investments from HealthCap, TPG Biotechnology Ventures, Genesys Capital and founding seed investor, the Fight Against Cancer Innovation Trust (FACIT). Fusion’s lead program — FPX-01 0151 — leverages alpha particle-emitting technology combined with monoclonal antibodies to target cancer cells with reduced damage to normal tissue and fewer side effects. The company’s platform is based on radiolabelling technologies developed by CPDC, a Centre of Excellence for Commercialization and Research. The financing will also help Toronto-based Fusion build a pipeline through development of its recently acquired centryin-based targeting technology program which is now in preclinical development.
Trending by Topic
Research Money News
Save the Date!
Save the date! The 17th Annual Money Conference, “Breaking Through the Status Quo: Scaling Canada’s Innovation Game”, will take place on 10-11 April 2018 at the National Arts Centre in Ottawa. Early Bird Registration opens soon!Read More
R$ welcomes new editor to the team
Meet Veronica Silva Cusi, an award-winning multimedia journalist – and the newest addition to the R$ team.Read More
Welcome to the New R$
Welcome to the new R$ website, launched in beta mode January 2017. We welcome your feedback as we strive to make your reading experience as smooth and enjoyable as possible.
RE$EARCH MONEY welcomes its readers to submit articles of either 650 or 1,000 words for its popular Opinion Leader page, on topics of interest to the research and innovation community. We also welcome Letters to the Editor and other feedback. If you would like to submit an article or if your organization has news or events that it would like to appear in RE$EARCH MONEY please contact Mark Henderson, Managing Editor, for further information.
- National Research Council
- Natural Sciences and Engineering Research Council
- Canada Foundation for Innovation
- Technology Partnerships Canada
- Univ of Toronto
- Univ of British Columbia
- Canadian Institutes of Health Research
- McGill Univ
- Univ of Alberta
- Univ of Waterloo
Research Money on Twitter
- Loading tweets...